{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:21:18Z","timestamp":1787318478219,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:00:00Z","timestamp":1716076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Prostate International"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.prnil.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T03:37:26Z","timestamp":1716435446000},"page":"139-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The association between inflammatory bowel disease and risk of prostate cancer: a population-based retrospective study based on Korean National Health Insurance Service database"],"prefix":"10.1016","volume":"12","author":[{"given":"Gyoohwan","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeongdo","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Kwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungkuk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prnil.2024.05.001_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.prnil.2024.05.001_bib2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.prnil.2022.03.004","article-title":"Prostate diseases and microbiome in the prostate, gut, and urine","volume":"10","author":"Miyake","year":"2022","journal-title":"Prostate Int"},{"key":"10.1016\/j.prnil.2024.05.001_bib3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.prnil.2024.05.001_bib4","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.prnil.2024.05.001_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","article-title":"Prostate cancer and inflammation: the evidence","volume":"60","author":"Sfanos","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.prnil.2024.05.001_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2147\/JIR.S65979","article-title":"Inflammatory bowel disease: clinical aspects and treatments","volume":"7","author":"Fakhoury","year":"2014","journal-title":"J\u00a0Inflamm Res"},{"key":"10.1016\/j.prnil.2024.05.001_bib7","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.clinre.2019.07.003","article-title":"An increase in prostate cancer diagnosis during inflammatory bowel disease: a systematic review and meta-analysis","volume":"44","author":"Chen","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.prnil.2024.05.001_bib8","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.cgh.2007.07.012","article-title":"The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States","volume":"5","author":"Kappelman","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.prnil.2024.05.001_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12328-017-0813-5","article-title":"Gut microbiota in the pathogenesis of inflammatory bowel disease","volume":"11","author":"Nishida","year":"2018","journal-title":"Clin J Gastroenterol"},{"key":"10.1016\/j.prnil.2024.05.001_bib10","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.prnil.2024.05.001_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s12029-022-00816-0","article-title":"Risk of cancer in inflammatory bowel disease and pitfalls in oncologic therapy","volume":"54","author":"Peixoto","year":"2022","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.prnil.2024.05.001_bib12","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.eururo.2018.11.039","article-title":"Inflammatory bowel disease and the risk of prostate cancer","volume":"75","author":"Burns","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.prnil.2024.05.001_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.imr.2021.100797","article-title":"A\u00a0brief introduction to research based on real-world evidence: considering the Korean National Health Insurance Service database","volume":"11","author":"Ahn","year":"2022","journal-title":"Integr Med Res"},{"key":"10.1016\/j.prnil.2024.05.001_bib14","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prnil.2024.05.001_bib15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev-immunol-020711-075008","article-title":"Cancer and inflammation: an old intuition with rapidly evolving new concepts","volume":"30","author":"Trinchieri","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.prnil.2024.05.001_bib16","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.21037\/tau-20-1358","article-title":"Inflammatory bowel disease and risk of urinary cancers: a systematic review and pooled analysis of population-based studies","volume":"10","author":"Feng","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.prnil.2024.05.001_bib17","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/ijc.33048","article-title":"Association between inflammatory bowel disease and prostate cancer: a large-scale, prospective, population-based study","volume":"147","author":"Meyers","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.prnil.2024.05.001_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41391-019-0177-7","article-title":"The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis","volume":"23","author":"Ge","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prnil.2024.05.001_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.21037\/tau-20-1020","article-title":"Does inflammatory bowel disease increase the risk of lower urinary tract tumors: a meta-analysis","volume":"10","author":"Zhang","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.prnil.2024.05.001_bib20","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","article-title":"Cancer risk in the early stages of inflammatory bowel disease in Korean patients: a nationwide population-based study","volume":"11","author":"Jung","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.prnil.2024.05.001_bib21","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/iju.14894","article-title":"Gut microbiome and prostate cancer","volume":"29","author":"Fujita","year":"2022","journal-title":"Int J Urol"},{"key":"10.1016\/j.prnil.2024.05.001_bib22","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.prnil.2024.05.001_bib23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41391-018-0041-1","article-title":"The microbiome in prostate inflammation and prostate cancer","volume":"21","author":"Porter","year":"2018","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"Suppl 1","key":"10.1016\/j.prnil.2024.05.001_bib24","first-page":"S6","article-title":"Helicobacter pylori and gastric cancer: a state of the art review","volume":"8","author":"Ishaq","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.prnil.2024.05.001_bib25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/ecco-jcc\/jjac156","article-title":"Mortality in patients with inflammatory bowel disease: results from 30 years of follow-up in a Norwegian inception cohort (the IBSEN study)","volume":"17","author":"Follin-Arbelet","year":"2023","journal-title":"J\u00a0Crohns Colitis"}],"container-title":["Prostate International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S228788822400031X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S228788822400031X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T18:19:21Z","timestamp":1726597161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S228788822400031X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S228788822400031X"],"URL":"https:\/\/doi.org\/10.1016\/j.prnil.2024.05.001","relation":{},"ISSN":["2287-8882"],"issn-type":[{"value":"2287-8882","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between inflammatory bowel disease and risk of prostate cancer: a population-based retrospective study based on Korean National Health Insurance Service database","name":"articletitle","label":"Article Title"},{"value":"Prostate International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prnil.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Asian Pacific Prostate Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}